PROMETHEON PHARMA

Platform biotech from University of Florida with needle-free transdermal patch delivery of large molecules. So far insulin, IGF-1, and hGH- 100x bigger than nicotine molecules delivered successfully to boost patient compliance and access. Initial $20B/year market with industry collaboration model that generates revenue before product launch.